King Legacy, a wholly owned subsidiary of Pfizer recalls
King Legacy, a wholly owned subsidiary of Pfizer has 11 recalls on record with the FDA and USDA, the earliest in 2013 and the latest reported on 29 May 2013. The most frequent reason is potency & assay.
Total recalls 11 since 2013
Last 12 months 0 reported
Class I 0 0% of total
Ongoing 0 latest 29 May 2013
Recalls per month, last 24 months click a bar for that month Severity split
0 0%11 100%0 0%
Why king legacy, a wholly owned subsidiary of pfizer is recalled
All king legacy, a wholly owned subsidiary of pfizer recalls, newest first 11 total Reported Class Recall Company Reason Where 29 May 2013 Drug CLASS II Levoxyl (levothyroxine sodium) tablets, USP, 125 mcg recalled Levoxyl King Legacy, a wholly owned subsidiary of Pfizer Potency & Assay Nationwide 29 May 2013 Drug CLASS II Levoxyl (levothyroxine sodium) tablets, USP, 100 mcg recalled Levoxyl King Legacy, a wholly owned subsidiary of Pfizer Potency & Assay Nationwide 29 May 2013 Drug CLASS II Levoxyl (levothyroxine sodium) tablets, USP, 75 mcg recalled Levoxyl King Legacy, a wholly owned subsidiary of Pfizer Potency & Assay Nationwide 29 May 2013 Drug CLASS II Levoxyl (levothyroxine sodium) tablets, USP, 200 mcg recalled Levoxyl King Legacy, a wholly owned subsidiary of Pfizer Potency & Assay Nationwide 29 May 2013 Drug CLASS II Levoxyl (levothyroxine sodium) tablets, USP, 150 mcg recalled Levoxyl King Legacy, a wholly owned subsidiary of Pfizer Potency & Assay Nationwide 29 May 2013 Drug CLASS II Levoxyl (levothyroxine sodium) tablets, USP, 50 mcg recalled Levoxyl King Legacy, a wholly owned subsidiary of Pfizer Potency & Assay Nationwide 29 May 2013 Drug CLASS II Levoxyl (levothyroxine sodium) tablets, USP, 112 mcg recalled Levoxyl King Legacy, a wholly owned subsidiary of Pfizer Potency & Assay Nationwide 29 May 2013 Drug CLASS II Levoxyl (levothyroxine sodium) tablets, USP, 25 mcg recalled Levoxyl King Legacy, a wholly owned subsidiary of Pfizer Potency & Assay Nationwide 29 May 2013 Drug CLASS II Levoxyl (levothyroxine sodium) tablets, USP, 175 mcg recalled Levoxyl King Legacy, a wholly owned subsidiary of Pfizer Potency & Assay Nationwide 29 May 2013 Drug CLASS II Levoxyl (levothyroxine sodium) tablets, USP, 88 mcg recalled Levoxyl King Legacy, a wholly owned subsidiary of Pfizer Potency & Assay Nationwide 29 May 2013 Drug CLASS II Levoxyl (levothyroxine sodium) tablets, USP, 137 mcg recalled Levoxyl King Legacy, a wholly owned subsidiary of Pfizer Potency & Assay Nationwide
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.